نتایج جستجو برای: tumor peptide

تعداد نتایج: 576890  

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011
Sander M J van Duijnhoven Marc S Robillard Klaas Nicolay Holger Grüll

UNLABELLED Activatable cell-penetrating peptides (ACPPs) are a new class of promising molecular imaging probes for the visualization of enzymes in vivo. The cell-penetrating function of a polycationic peptide is efficiently blocked by intramolecular electrostatic interactions with a polyanionic peptide. Proteolysis of a cleavable linker present between the polycationic cell-penetrating peptide ...

Journal: :Annals of Oncology 2022

The passive application of Trastuzumab and Pertuzumab has demonstrated remarkable success in the clinical outcome patients with Her-2/neu positive metastatic breast cancer. However, active immunization mimotope/B cell epitope-based vaccines can induce production corresponding mAbs by patient’s immune system. We have developed a B peptide-based vaccine (HerVaxx) comprising Trastuzumab’s binding ...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه پیام نور - دانشگاه پیام نور استان تهران - دانشکده علوم پایه 1387

گلوتامین مهمترین و غالبترین اسیدآمینه موجوددرخون میباشدکه یک منبع آمینواسیدی آزاددرعضلات اسکلتی بوده و در بدن به عنوان منبع مهم انرژی عمل می کند.در تمرینات شدیدو طولانی مدت سطح گلوتامین پلاسما کاهش می یابدو نشانه هایی از تغییرات در متابولیسم گلوکز و هورمونهای متابولیکی مربوطه مشاهده می گردد که میتواند باعث ضعف,خستگی و نهایتاتحلیل عضلانی در ورزشکاران شود.جهت بررسی تاثیر مصرف مکمل گلوتامین بر سطح...

Journal: :Journal of immunology 2006
Vaughan P Wittman David Woodburn Tiffany Nguyen Francisca A Neethling Stephen Wright Jon A Weidanz

Therapeutic mAbs that target tumor-associated Ags on the surface of malignant cells have proven to be an effective and specific option for the treatment of certain cancers. However, many of these protein markers of carcinogenesis are not expressed on the cells' surface. Instead these tumor-associated Ags are processed into peptides that are presented at the cell surface, in the context of MHC c...

Journal: :Cancer research 2002
Cyril J Cohen Noa Hoffmann Marganit Farago Hennie R Hoogenboom Lea Eisenbach Yoram Reiter

The recent characterization of MHC-displayed tumor-associated antigens that recognize effector cells of the immune system has created new perspectives for cancer therapy. Antibodies that recognize these tumor-associated MHC-peptide complexes with the same specificity as the T-cell antigen receptor will therefore be valuable tools for immunotherapy, as well as for studying antigen presentation i...

Journal: :Journal of Immunology 2023

Abstract Human leucocyte antigens (HLAs) display a repertoire of epitopic peptides on the cell surface for T recognition. Amino acid polymorphisms in peptide-binding groove different HLA allotypes result distinct antigenic repertoires, providing basis adaptive immunity to emerging pathogens at population level. receptors (TCRs) recognize pHLA through interactions with both peptide and heavy cha...

2014
Hou Dong Zuo Wei Wu Yao Tian Wu Chen Jiang Zhu Juan Juan Zhang Yu Pu Gang Liu Xiao Ming Zhang

The iRGD peptide loaded with iron oxide nanoparticles for tumor targeting and tissue penetration was developed for targeted tumor therapy and ultrasensitive MR imaging. Binding of iRGD, a tumor homing peptide, is mediated by integrins, which are widely expressed on the surface of cells. Several types of small molecular drugs and nanoparticles can be transfected into cells with the help of iRGD ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2004
Avital Lev Roy Noy Kfir Oved Hila Novak Dina Segal Peter Walden Dietmar Zehn Yoram Reiter

A cancer immunotherapy strategy is described herein that combines the advantage of the well established tumor targeting capabilities of high-affinity recombinant fragments of Abs with the known efficient, specific, and potent killing ability of CD8 T lymphocytes directed against highly antigenic MHC-peptide complexes. Structurally, it consists of a previously uncharacterized class of recombinan...

2001
JC Cerottini Bruno Robert Philippe Guillaume Immanuel Luescher Marie-Agnès Doucey Jean-Charles Cerottini Pedro Romero Jean-Pierre Mach

To combine the advantage of both the tumor targeting capacity of high affinity monoclonal antibodies (mAbs) and the potent killing properties of cytotoxic T lymphocytes (CTL), we investigated the activity of conjugates made by coupling single Fab' fragments, from mAbs specific for tumor cell surface antigens, to monomeric HLA-A2 complexes containing the immunodominant influenza-matrix peptide 5...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید